{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:27:59Z","timestamp":1763458079195,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008593","name":"European Respiratory Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ejim.2022.01.023","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T08:23:41Z","timestamp":1642753421000},"page":"4-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Critical appraisal of international adult bronchiectasis guidelines using the AGREE II tool"],"prefix":"10.1016","volume":"98","author":[{"given":"Sofia","family":"Tejada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Ram\u00edrez-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre M.","family":"Tejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos G.","family":"Forero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Pomares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan B.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10150","key":"10.1016\/j.ejim.2022.01.023_bib0001","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejim.2022.01.023_bib0002","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10096-019-03748-z","article-title":"Evidence supporting recommendations from international guidelines on treatment, diagnosis, and prevention of HAP and VAP in adults","volume":"39","author":"Campogiani","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.ejim.2022.01.023_bib0003","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s10096-020-03833-8","article-title":"Levels of evidence supporting European and American community-acquired pneumonia guidelines","volume":"39","author":"Ferreira-Coimbra","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ejim.2022.01.023_bib0004","first-page":"497","article-title":"Quality of evidence supporting Surviving Sepsis Campaign Recommendations","volume":"39","author":"Rello","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"5","key":"10.1016\/j.ejim.2022.01.023_bib0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10096-019-03794-7","article-title":"Levels of evidence supporting clinical practice guidelines on invasive aspergillosis","volume":"39","author":"Tejada","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ejim.2022.01.023_bib0006","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"18","key":"10.1016\/j.ejim.2022.01.023_bib0007","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"10","key":"10.1016\/j.ejim.2022.01.023_bib0008","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1503\/cmaj.091714","article-title":"Development of the AGREE II, part 1: performance, usefulness and areas for improvement","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"10","key":"10.1016\/j.ejim.2022.01.023_bib0009","doi-asserted-by":"crossref","first-page":"E472","DOI":"10.1503\/cmaj.091716","article-title":"Development of the AGREE II, part 2: assessment of validity of items and tools to support application","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.ejim.2022.01.023_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/qhc.12.1.18","article-title":"Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project","volume":"12","year":"2003","journal-title":"Qual Saf Health Care"},{"year":"2017","series-title":"The AGREE II Instrument [Internet]","author":"AGREE Next Steps Consortium","key":"10.1016\/j.ejim.2022.01.023_bib0011"},{"article-title":"Original AGREE Instrument - AGREE Enterprise website [Internet]","year":"2003","series-title":"AGREE, Advancing the science of practice guidelines","key":"10.1016\/j.ejim.2022.01.023_bib0012"},{"issue":"2","key":"10.1016\/j.ejim.2022.01.023_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Spanish Guidelines on Treatment of Bronchiectasis in Adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.ejim.2022.01.023_bib0014","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ejim.2022.01.023_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/mja14.00287","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines","volume":"202","author":"Chang","year":"2015","journal-title":"Med J Aust"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2022.01.023_bib0016","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.ejim.2022.01.023_bib0017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1157\/13128330","article-title":"Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery","volume":"44","author":"Vendrell","year":"2008","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"10.1016\/j.ejim.2022.01.023_bib0018","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Med J Aust"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2022.01.023_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society Guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ejim.2022.01.023_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","article-title":"Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.ejim.2022.01.023_bib0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/atm.ATM_171_17","article-title":"The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis","volume":"12","author":"Al-Jahdali","year":"2017","journal-title":"Ann Thorac Med"},{"issue":"2","key":"10.1016\/j.ejim.2022.01.023_bib0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4104\/pcrj.2011.00007","article-title":"Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis","volume":"20","author":"Hill","year":"2011","journal-title":"Prim Care Respir J"},{"year":"2002","series-title":"Sign 50: A Guideline Developer's Handbook. [Internet]","key":"10.1016\/j.ejim.2022.01.023_bib0023"},{"year":"2017","series-title":"Technical Quality and Clinical Acceptability of a Utilization Review Guideline for Occupational Conditions: ODG\u00ae Treatment Guidelines by the Work Loss Data Institute","author":"Nuckols","key":"10.1016\/j.ejim.2022.01.023_bib0024"},{"issue":"156","key":"10.1016\/j.ejim.2022.01.023_bib0025","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0120-2019","article-title":"The radiological diagnosis of bronchiectasis: what's in a name?","volume":"29","author":"Tiddens","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ejim.2022.01.023_bib0026","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2021.04.009","article-title":"Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"90","author":"Tejada","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2022.01.023_bib0027","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/thoraxjnl-2013-203739","article-title":"National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?","volume":"69","author":"Hill","year":"2014","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.ejim.2022.01.023_bib0028","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:35:11Z","timestamp":1760607311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":28,"alternative-id":["S0953620522000358"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.01.023","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical appraisal of international adult bronchiectasis guidelines using the AGREE II tool","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}